Results 211 to 220 of about 1,228,387 (374)

Drug Resistance Predictions Based on a Directed Flag Transformer

open access: yesAdvanced Science, EarlyView.
 CAPTURE, a deep learning framework combining structural and sequence data to predict drug‐resistant Mpro mutations, revealing that PAXLOVID use may be accelerating resistance—supporting real‐time viral surveillance and therapeutic design. Abstract The evolving SARS‐CoV‐2 virus threatens global public health, particularly with potential resistance to ...
Dong Chen   +8 more
wiley   +1 more source

“Recordando la parotiditis en la era del SARS-CoV-2”

open access: green, 2000
Anabela Salgueiro Marques   +2 more
openalex   +1 more source

The Conceptual Framework for SARS-CoV-2 Related Lymphopenia

open access: green, 2020
Ilnaz Rahimmanesh   +2 more
openalex   +1 more source

Variants of SARS-CoV-2 [PDF]

open access: yesJAMA, 2021
Preeti N. Malani, Adam S. Lauring
openaire   +2 more sources

Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic Modulation

open access: yesAdvanced Science, EarlyView.
This article comprehensively explores the pivotal role of mitochondrial function in CD8⁺ T cell immunotherapy. It highlights how mitochondrial dynamics regulate T cell activation, differentiation, and persistence, and how mitochondrial dysfunction leads to immune exhaustion and impaired antitumor/antiviral responses.
Xu Chen   +7 more
wiley   +1 more source

SARS‐CoV‐2 vaccinations can trigger polyradiculitis

open access: yesClinical Case Reports, 2022
Josef Finsterer, Talal Almas
doaj   +1 more source

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

open access: yesInternational Journal of Antimicrobial Agents, 2020
Chih-Cheng Lai   +4 more
semanticscholar   +1 more source

Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction

open access: green, 2005
T HO   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy